Ownership history in Redmile Group, LLC · 60 quarters on record
This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in AMICUS THERAPEUTICS INC COM (FOLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 777,178 | -411,820 | -34.6% | 0.60% | $6.1M | $7.88 |
| 2025 Q2 | REDUCED | 1,188,998 | -8,344,671 | -87.5% | 0.73% | $6.8M | $5.73 |
| 2025 Q1 | ADDED | 9,533,669 | +2,478,779 | +35.1% | 7.35% | $77.8M | $8.16 |
| 2024 Q4 | REDUCED | 7,054,890 | -1,191,702 | -14.5% | 4.63% | $66.5M | $9.42 |
As of 2025 Q4 — sorted by position size